A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension.
about
Chemical and biological assessment of metal organic frameworks (MOFs) in pulmonary cells and in an acute in vivo model: relevance to pulmonary arterial hypertension therapy.New perspectives in nanotherapeutics for chronic respiratory diseases.Systems biology: An emerging strategy for discovering novel pathogenetic mechanisms that promote cardiovascular disease.Nitric oxide and pulmonary arterial hypertension.
P2860
A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension.
@en
A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension.
@nl
type
label
A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension.
@en
A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension.
@nl
prefLabel
A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension.
@en
A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension.
@nl
P2093
P2860
P1476
A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension
@en
P2093
Adrian H Chester
Beata Wojciak-Stothard
Blerina Ahmetaj-Shala
Daniel M Reed
Gemma R Freeman
Ibrahim M El-Sherbiny
Jane A Mitchell
Lucie Duluc
Magdi H Yacoub
Nicholas S Kirkby
P2860
P2888
P304
P356
10.1007/S12265-016-9684-2
P407
P50
P577
2016-03-09T00:00:00Z